WEKO3
アイテム
{"_buckets": {"deposit": "0c8867c3-f1eb-44d2-9abd-ef80ca9b3da6"}, "_deposit": {"created_by": 12, "id": "1183", "owners": [12], "pid": {"revision_id": 0, "type": "depid", "value": "1183"}, "status": "published"}, "_oai": {"id": "oai:jichi-ir.repo.nii.ac.jp:00001183", "sets": ["5"]}, "author_link": [], "item_4_date_granted_11": {"attribute_name": "学位授与年月日", "attribute_value_mlt": [{"subitem_dategranted": "2022-06-22"}]}, "item_4_degree_grantor_9": {"attribute_name": "学位授与機関", "attribute_value_mlt": [{"subitem_degreegrantor": [{"subitem_degreegrantor_name": "自治医科大学"}], "subitem_degreegrantor_identifier": [{"subitem_degreegrantor_identifier_name": "32202", "subitem_degreegrantor_identifier_scheme": "kakenhi"}]}]}, "item_4_degree_name_8": {"attribute_name": "学位名", "attribute_value_mlt": [{"subitem_degreename": "博士(医学)"}]}, "item_4_description_10": {"attribute_name": "学位授与年度", "attribute_value_mlt": [{"subitem_description": "令和4年度", "subitem_description_type": "Other"}]}, "item_4_dissertation_number_12": {"attribute_name": "学位授与番号", "attribute_value_mlt": [{"subitem_dissertationnumber": "乙第827号"}]}, "item_4_full_name_3": {"attribute_name": "著者別名", "attribute_value_mlt": [{"names": [{"name": "Ohara, Ken", "nameLang": "en"}]}]}, "item_4_relation_15": {"attribute_name": "関連サイト", "attribute_value_mlt": [{"subitem_relation_name": [{"subitem_relation_name_text": "掲載雑誌:Nephrology(出版社:Wiley)"}], "subitem_relation_type_id": {"subitem_relation_type_id_text": "https://doi.org/10.1111/nep.13552", "subitem_relation_type_select": "DOI"}}, {"subitem_relation_name": [{"subitem_relation_name_text": "掲載雑誌:Diabetology \u0026 Metabolic Syndrome(出版社:BioMed Central)"}], "subitem_relation_type_id": {"subitem_relation_type_id_text": "https://doi.org/10.1186/s13098-020-00545-z", "subitem_relation_type_select": "DOI"}}]}, "item_4_relation_16": {"attribute_name": "他の資源との関係", "attribute_value_mlt": [{"subitem_relation_name": [{"subitem_relation_name_text": "Effects of the sodium-glucose cotransporter 2 inhibitor dapagliflozin on fluid distribution: A comparison study with furosemide and tolvapta"}]}, {"subitem_relation_name": [{"subitem_relation_name_text": "The extracellular volume status predicts body fluid response to SGLT2 inhibitor dapagliflozin in diabetic kidney disease"}]}]}, "item_4_version_type_18": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_970fb48d4fbd8a85", "subitem_version_type": "VoR"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "open access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_abf2"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "大原, 健", "creatorNameLang": "ja"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2022-09-22"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "【乙種】学位論文_827 大原 健氏.pdf", "filesize": [{"value": "1.4 MB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_11", "mimetype": "application/pdf", "size": 1400000.0, "url": {"label": "【乙種】学位論文_827 大原 健氏", "objectType": "fulltext", "url": "https://jichi-ir.repo.nii.ac.jp/record/1183/files/【乙種】学位論文_827 大原 健氏.pdf"}, "version_id": "5a9184da-15a2-40b2-8be5-58991d795587"}, {"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2022-09-22"}], "displaytype": "detail", "download_preview_message": "", "file_order": 1, "filename": "【乙種】論文要旨及び審査結果_827 大原 健氏.pdf", "filesize": [{"value": "285.5 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensetype": "license_11", "mimetype": "application/pdf", "size": 285500.0, "url": {"label": "【乙種】論文要旨及び審査結果_827 大原 健氏", "objectType": "abstract", "url": "https://jichi-ir.repo.nii.ac.jp/record/1183/files/【乙種】論文要旨及び審査結果_827 大原 健氏.pdf"}, "version_id": "5dceeb4d-47cf-4416-8c7a-8bd2faddd623"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "jpn"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "doctoral thesis", "resourceuri": "http://purl.org/coar/resource_type/c_db06"}]}, "item_title": "SGLT2阻害薬が体液量に及ぼす効果:ループ利尿薬、バソプレシンV2受容体拮抗薬との比較検討", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "SGLT2阻害薬が体液量に及ぼす効果:ループ利尿薬、バソプレシンV2受容体拮抗薬との比較検討", "subitem_title_language": "ja"}]}, "item_type_id": "4", "owner": "12", "path": ["5"], "permalink_uri": "https://jichi-ir.repo.nii.ac.jp/records/1183", "pubdate": {"attribute_name": "PubDate", "attribute_value": "2022-09-22"}, "publish_date": "2022-09-22", "publish_status": "0", "recid": "1183", "relation": {}, "relation_version_is_last": true, "title": ["SGLT2阻害薬が体液量に及ぼす効果:ループ利尿薬、バソプレシンV2受容体拮抗薬との比較検討"], "weko_shared_id": -1}
SGLT2阻害薬が体液量に及ぼす効果:ループ利尿薬、バソプレシンV2受容体拮抗薬との比較検討
https://jichi-ir.repo.nii.ac.jp/records/1183
https://jichi-ir.repo.nii.ac.jp/records/11834e1b89f8-7f54-43eb-a567-40051b2917cc
名前 / ファイル | ライセンス | アクション |
---|---|---|
![]() |
||
![]() |
Item type | 学位論文 / Thesis or Dissertation(1) | |||||||
---|---|---|---|---|---|---|---|---|
公開日 | 2022-09-22 | |||||||
タイトル | ||||||||
言語 | ja | |||||||
タイトル | SGLT2阻害薬が体液量に及ぼす効果:ループ利尿薬、バソプレシンV2受容体拮抗薬との比較検討 | |||||||
言語 | ||||||||
言語 | jpn | |||||||
資源タイプ | ||||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_db06 | |||||||
資源タイプ | doctoral thesis | |||||||
アクセス権 | ||||||||
アクセス権 | open access | |||||||
アクセス権URI | http://purl.org/coar/access_right/c_abf2 | |||||||
著者 |
大原, 健
× 大原, 健
|
|||||||
著者別名 | ||||||||
姓名 | Ohara, Ken | |||||||
言語 | en | |||||||
学位名 | ||||||||
学位名 | 博士(医学) | |||||||
学位授与機関 | ||||||||
学位授与機関識別子Scheme | kakenhi | |||||||
学位授与機関識別子 | 32202 | |||||||
学位授与機関名 | 自治医科大学 | |||||||
学位授与年度 | ||||||||
内容記述タイプ | Other | |||||||
内容記述 | 令和4年度 | |||||||
学位授与年月日 | ||||||||
学位授与年月日 | 2022-06-22 | |||||||
学位授与番号 | ||||||||
学位授与番号 | 乙第827号 | |||||||
関連サイト | ||||||||
識別子タイプ | DOI | |||||||
関連識別子 | https://doi.org/10.1111/nep.13552 | |||||||
関連名称 | 掲載雑誌:Nephrology(出版社:Wiley) | |||||||
関連サイト | ||||||||
識別子タイプ | DOI | |||||||
関連識別子 | https://doi.org/10.1186/s13098-020-00545-z | |||||||
関連名称 | 掲載雑誌:Diabetology & Metabolic Syndrome(出版社:BioMed Central) | |||||||
他の資源との関係 | ||||||||
関連名称 | Effects of the sodium-glucose cotransporter 2 inhibitor dapagliflozin on fluid distribution: A comparison study with furosemide and tolvapta | |||||||
他の資源との関係 | ||||||||
関連名称 | The extracellular volume status predicts body fluid response to SGLT2 inhibitor dapagliflozin in diabetic kidney disease | |||||||
著者版フラグ | ||||||||
出版タイプ | VoR | |||||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 |